Company attributes
Industry
Pitchbook URL
Number of Employees (Ranges)
51 – 2000
Full Address
201 Haskins Way, Suite 203 South San Francisco, CA 94080, United States0
410 W Harrison St, Suite 300 Seattle, WA 98119, United States0
Investors
Email Address
partnerships@sonomabio.com0
media@sonomabio.com0
info@sonomabio.com0
Total Funding Amount (USD)
295,000,000
Latest Funding Round Date
August 4, 2021
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
265,000,000
Sonoma Biotherapeutics is a privately held, San Francisco and Seattle-based company developing adoptive Treg therapies cell for autoimmune and degenerative diseases. Using genome editing and target-specific cell therapy, Sonoma is focused on developing the entire spectrum of Treg cell therapeutic capabilities. .
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.